A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma
University of Nebraska
University of Nebraska
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
University of California, San Francisco
NYU Langone Health
Case Comprehensive Cancer Center
Mayo Clinic
Memorial Sloan Kettering Cancer Center
Novartis
Tactical Therapeutics, Inc.
University of Miami
Candel Therapeutics, Inc.
Center Trials & Treatment Europe
Institut Cancerologie de l'Ouest
Vanderbilt-Ingram Cancer Center
Celgene
Amsterdam UMC, location VUmc
Lumos Pharma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Duke University
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC
Duke University
Duke University
National Cancer Institute (NCI)
Duke University
Duke University
Duke University
Sanofi
National Cancer Institute (NCI)
Duke University
Duke University
City of Hope Medical Center
Northwestern University
INSYS Therapeutics Inc
NYU Langone Health
City of Hope Medical Center
Case Comprehensive Cancer Center